ArticleInternational journal of women's health2026
Effect of Transcutaneous Electrical Acupoint Stimulation on Postoperative Urinary Retention After Radical Hysterectomy for Cervical Cancer: Study Protocol for A Pilot Randomized Controlled Trial.
Article in International journal of women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Postoperative urinary retention (POUR) is a common complication in women after radical hysterectomy for cervical cancer and may substantially impair quality of life. Transcutaneous Electrical Acupoint Stimulation (TEAS) has shown potential in alleviating POUR, but its efficacy remains to be further evaluated. This pilot study aims to preliminarily evaluate the effect of TEAS in women who develop POUR after radical hysterectomy for cervical cancer. Methods and Analysis: This protocol describes a prospective, single-blinded, single-center pilot randomized controlled trial that will compare TEAS with sham TEAS for the management of POUR after radical hysterectomy for cervical cancer. A total of 76 eligible patients will be randomly assigned in a 1:1 ratio to the TEAS group or the sham TEAS group. Participants in the TEAS group will receive TEAS once daily for 2 weeks, while those in the sham TEAS group will receive sham stimulation on the same schedule. The primary outcome is the change in post-void residual (PVR) volume. Secondary outcomes include the rate of successful urinary catheter removal, incidence of urinary tract infection (UTI), and quality of life assessed using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30 (EORTC QLQ-C30). Safety will also be evaluated. All statistical analyses will be conducted according to the intention-to-treat (ITT) principle. Ethics/Dissemination: The trial has received ethics approval from the Medical Ethics Committee of Zhejiang Cancer Hospital (14 October 2025; IRB-2025-1262). Findings will be disseminated in peer-reviewed journals to inform clinical decision-making in POUR management. Trial Registration Number: ITMCTR2025002091.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.